The epidemic of cardiovascular disease in South Asians: Time for action

[1]  R. Josephson,et al.  Rationale and design of a cluster-randomized controlled trial to evaluate the effects of a community health worker-based program for cardiovascular risk factor control in India. , 2017, American heart journal.

[2]  S. Yusuf,et al.  Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study , 2016, The Lancet.

[3]  S. Yusuf,et al.  Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[4]  S. Yusuf,et al.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[5]  S. Yusuf,et al.  Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial. , 2016, The lancet. Diabetes & endocrinology.

[6]  S. Yusuf,et al.  Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data , 2016, The Lancet.

[7]  S. Yusuf,et al.  Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study , 2015, European journal of preventive cardiology.

[8]  V. Ajay,et al.  A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India , 2015, Circulation.

[9]  P. Jose,et al.  Cardiovascular disease mortality in Asian Americans. , 2014, Journal of the American College of Cardiology.

[10]  Sonia S Anand,et al.  Cardiovascular risk among South Asians living in Canada: a systematic review and meta-analysis. , 2014, CMAJ open.

[11]  S. Yusuf,et al.  Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies , 2014, PloS one.

[12]  T. Kawada.  Letter by Kawada regarding article, "Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation". , 2013, Stroke.

[13]  Martin McKee,et al.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. , 2013, JAMA.

[14]  S. Yusuf,et al.  Dabigatran Versus Warfarin: Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation , 2013, Stroke.

[15]  Mark D. Huffman,et al.  Optimal In-Hospital and Discharge Medical Therapy in Acute Coronary Syndromes in Kerala: Results From the Kerala Acute Coronary Syndrome Registry , 2013, Circulation. Cardiovascular quality and outcomes.

[16]  S. Yusuf,et al.  Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. , 2009, Journal of the American College of Cardiology.

[17]  S. Yusuf,et al.  Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data , 2008, The Lancet.

[18]  Prabhat Jha,et al.  A nationally representative case-control study of smoking and death in India. , 2008, The New England journal of medicine.

[19]  S. Yusuf,et al.  Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. , 2007, JAMA.

[20]  Salim Yusuf,et al.  Comparison of fondaparinux and enoxaparin in acute coronary syndromes. , 2006, The New England journal of medicine.

[21]  S. Yusuf,et al.  Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. , 2006, JAMA.

[22]  S. Yusuf,et al.  Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. , 2005, JAMA.

[23]  S. Yusuf,et al.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) , 2000, The Lancet.

[24]  Sonia S Anand,et al.  Classifying ethnicity utilizing the Canadian Mortality Data Base. , 1997, Ethnicity and Health.

[25]  Salim Yusuf,et al.  Risk factors for acute myocardial infarction in Indians: a case-control study , 1996, The Lancet.

[26]  J. Mehta,et al.  Prevalence of coronary artery disease in Asian Indians. , 1992, American Journal of Cardiology.

[27]  P. Pais,et al.  Dabigatran Versus Warfarin Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation the RE-LY Investigators , 2013 .